Results 161 to 170 of about 16,226 (208)

Formulation and candidacidal activity of magnetic nanoparticles coated with cathelicidin LL-37 and ceragenin CSA-13. [PDF]

Sci Rep, 2017
Niemirowicz K, Durnaś B, Tokajuk G, Piktel E, Michalak G, Gu X, Kułakowska A, Savage PB, Bucki R.   +8 more
europepmc   +1 more source

Retraction Note: Human cathelicidin LL-37 enhance the antibiofilm effect of EGCG on Streptococcus mutans. [PDF]

BMC Oral Health, 2017
Guo YJ, Zhang B, Feng XS, Ren HX, Xu JR.
europepmc   +1 more source

Carbon Nanoparticles Inhibit the Antimicrobial Activities of the Human Cathelicidin LL-37 through Structural Alteration. [PDF]

J Immunol, 2017
Findlay F, Pohl J, Svoboda P, Shakamuri P, McLean K, Inglis NF, Proudfoot L, Barlow PG.   +7 more
europepmc   +1 more source

Anaerobic bacteria growth in the presence of cathelicidin LL-37 and selected ceragenins delivered as magnetic nanoparticles cargo. [PDF]

BMC Microbiol, 2017
Durnaś B, Piktel E, Wątek M, Wollny T, Góźdź S, Smok-Kalwat J, Niemirowicz K, Savage PB, Bucki R.   +8 more
europepmc   +1 more source

Impact of low-level laser therapy on the dynamics of pressure ulcer-induced changes considering an infectious agent and cathelicidin LL-37 concentration: a preliminary study. [PDF]

Postepy Dermatol Alergol, 2018
Brauncajs M, Ksiąszczyk K, Lewandowska-Polak A, Gorzela K, Grzegorczyk J.   +4 more
europepmc   +1 more source

Mirolysin, a LysargiNase from Tannerella forsythia, proteolytically inactivates the human cathelicidin, LL-37. [PDF]

Biol Chem, 2017
Koneru L, Ksiazek M, Waligorska I, Straczek A, Lukasik M, Madej M, Thøgersen IB, Enghild JJ, Potempa J.   +8 more
europepmc   +1 more source

The RLR/NLR expression and pro-inflammatory activity of tissue mast cells are regulated by cathelicidin LL-37 and defensin hBD-2. [PDF]

Sci Rep, 2018
Agier J, Różalska S, Wiktorska M, Żelechowska P, Pastwińska J, Brzezińska-Błaszczyk E.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Cathelicidin LL-37 Expression in Human Breast Implant Capsules

Plastic & Reconstructive Surgery, 2023
Background: Capsular contracture is the most common complication following breast implant placement. Cathelicidin LL-37 is a cationic peptide involved in innate immunity. Initially investigated for its antimicrobial role, it was found to have pleiotropic activities, such as immunomodulation, angiogenesis stimulation, and tissue
Francesco, Segreto, Simone, Carotti, Giovanni Francesco, Marangi, Maria, Francesconi, Eleonora, Calia, Barbara, Cagli, Andrea, Cimmino, Caterina, Rossi, Sergio, Morini, Paolo, Persichetti   +9 more
openaire   +2 more sources

Cathelicidin LL-37: A Multitask Antimicrobial Peptide

Archivum Immunologiae et Therapiae Experimentalis, 2010
The antimicrobial peptide LL-37 is the only known member of the cathelicidin family of peptides expressed in humans. LL-37 is a multifunctional host defense molecule essential for normal immune responses to infection and tissue injury. LL-37 peptide is a potent killer of different microorganisms with the ability to prevent immunostimulatory effects of ...
Robert, Bucki, Katarzyna, Leszczyńska, Andrzej, Namiot, Wojciech, Sokołowski   +3 more
openaire   +3 more sources